News AbbVie's Immunogen buy delivers rare cancer drug approval AbbVie's Decnupaz approval will give patients with rare blood cancer BPDCN an alternative to Stemline's Elzonris with a simpler dosing regimen.
News Zuckerberg, Chan's Biohub launches protein 'world model' Chan Zuckberg Initiative-backed Biohub has made what it says is an AI-powered "world model" of protein biology available freely to researchers.
News FDA delays verdict on AZ breast cancer drug After an advisory committee setback, AstraZeneca has a chance to make the case for its oral SERD camizestrant for breast cancer.
News Heart drug developer Kardigan files IPO The steady stream of biotech IPOs on the Nasdaq this year has continued, with Kardigan the latest to make its intention to list known.
News Roche launches liver disease algorithm panel Roche has introduced what it says is the first comprehensive panel of certified algorithms to help manage people living with chronic liver disease.
News Philanthropic drive puts $140m behind strep A vaccine A $140m fund launched by philanthropic group Coefficient Giving will try to find the first vaccine for Strep A, which kills 639,000 people a year.
News Kyverna builds case for CAR-T in stiff person syndrome Kyverna has data with miv-cel in stiff person syndrome that shows durable efficacy and safety and seems to sidestep issues flagged with other CAR-Ts.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.